SCHEMBL15727445

SCHEMBL15727445

CCOCC1(F)CCN(C)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 1/20 0.32
SCN9A Q15858 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12464685 0.88 VNN1 (0.36) VNN1
SCHEMBL18087419 0.80 SLC6A2 (0.36)
SCHEMBL19070179 0.79
SCHEMBL21216310 0.77
SCHEMBL23841640 0.76
SCHEMBL18084598 0.76
SCHEMBL24753273 0.74
SCHEMBL21859845 0.74 DRD4 (0.31)
SCHEMBL21779516 0.73
SCHEMBL18704543 0.72 VNN1 (0.34) VNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014078331-A1 N-(ARYLALKYL)-N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2014-05-22 WO disclosed